Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells April 25, 2017 Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells Trade Name Orphan Indication Asherman's syndrome EU Market Approval EU EU Designation Date 2017-04-20 00:00:00 Sponsor Igenomix, S.L.